Research letter
The effect of biologic therapy for immune-mediated inflammatory diseases on clinical outcomes of COVID-19 in the greater Houston area: A retrospective chart review

https://doi.org/10.1016/j.jaad.2021.12.054Get rights and content

Cited by (0)

Funding sources: None.

IRB approval status: Approved by the IRBs of MD Anderson and the University of Texas Health Science Center at Houston.

Key words: biologics; COVID-19; cytokines; dermatology; immunosuppression; interleukins.

Reprints not available from the authors.

View Abstract